Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
about
Neonatal host defense against Staphylococcal infectionsContribution of autolysin and Sortase a during Enterococcus faecalis DNA-dependent biofilm developmentUnderstanding the significance of Staphylococcus epidermidis bacteremia in babies and childrenVascular catheter-associated infections: a microbiological and therapeutic update.Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.Vancomycin: does it still have a role as an antistaphylococcal agent?Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.Daptomycin for the treatment of major gram-positive infections after cardiac surgery.Catheter removal versus retention in the management of catheter-associated enterococcal bloodstream infections.Daptomycin lock therapy for grampositive long-term catheter-related bloodstream infections.Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infectionsBiofilms in ventilator-associated pneumonia.Daptomycin antibiotic lock therapy for hemodialysis patients with Gram-positive bloodstream infections following use of tunneled, cuffed hemodialysis catheters: retrospective single center analysis.Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters[Daptomycin for the treatment of gram-positive infections after cardiac surgery].Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains
P2860
Q26823812-E16B6FB6-2469-4D0B-900B-73D13BA76BFFQ33467728-F70597B1-A85A-41A6-880B-100854A25412Q33870497-6D4EE919-5905-4A62-9E62-7EBD6B494E6AQ34585059-B1EC9772-80B4-4ACE-A2DE-DD7596F04D7AQ35110799-9998C633-8F8D-43A1-8994-8194FBA8407AQ36083208-BCBA7A1A-922B-44B5-BF3F-7A6E506BC421Q36777850-9960294E-D72E-43B6-8EEE-B48F3C8CEC36Q36839712-9C365335-C6F7-42C4-901F-D5D2DD6FCC66Q36847287-E097DB86-73A4-45D9-8DEB-0BFCD442A3DCQ37150644-8E440F15-E24D-4F02-A390-DA07CDE4801EQ37366736-D74C509E-BDA3-4E4E-87B5-A6C8D0519226Q37984783-311B2005-A501-4133-B01F-D5A1FB489FABQ38282725-9A9C79C7-E209-4CA1-A4A6-C899D9039EE4Q38796742-A02750BD-441F-4AC2-ADB4-AE4BD9EAEC69Q40131939-5B53259F-A059-436F-BB2F-03FD90480FA7Q42845932-97E9130B-A1C6-4D5C-9B7A-31D49728E255Q42846067-3A3DE8B4-B387-42BC-B451-01CC67C6E785Q44738071-93ED74F8-EB65-46E5-81BE-D925D5D7CCDCQ46343771-B3C3BD7D-D423-4932-AD46-5DB247FCFFBBQ58613682-481C0BE5-F85E-4759-A974-C11395506EFC
P2860
Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Antibacterial activity of line ...... catheter-related bacteraemia.
@en
Antibacterial activity of line ...... catheter-related bacteraemia.
@nl
type
label
Antibacterial activity of line ...... catheter-related bacteraemia.
@en
Antibacterial activity of line ...... catheter-related bacteraemia.
@nl
prefLabel
Antibacterial activity of line ...... catheter-related bacteraemia.
@en
Antibacterial activity of line ...... catheter-related bacteraemia.
@nl
P2093
P2860
P356
P1476
Antibacterial activity of line ...... catheter-related bacteraemia.
@en
P2093
Elizabeth A Coyle
Issam I Raad
Randall A Prince
P2860
P304
P356
10.1093/JAC/DKI106
P407
P577
2005-04-06T00:00:00Z